The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT04217291
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Sponsor
- Suzhou Yabao Pharmaceutical R&D Co., Ltd.
- Registry
-
NCT04217291
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04217291. Randomized; quadruple masking; primary purpose treatment. Start 2019-12-10 (actual); primary completion 2021-07-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- SY-004
- Intervention (Other)
- SY-004 matching placebo
- Lead sponsor
- Suzhou Yabao Pharmaceutical R&D Co., Ltd.
Record details
- Record id
cardio:ct-nct04217291- Content hash
4d40d65ee03ca5704d1fd9200c5e9737eac8e979619691db02e3a3f92f7713ef